Epilepsy, anti-epileptic medication use and risk of cancer

International Journal of Cancer

Volumn 134, Issue 4, 2014, Pages 932-938

  Kaae, Jeanette ^a,b   Carstensen, Lisbeth ^a   Wohlfahrt, Jan ^a   Melbye, Mads ^a   Allison Boyd, Heather ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

anti epileptic medication; cancer; epidemiology; epilepsy

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; DISEASE ASSOCIATION; DRUG USE; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PHARYNX CANCER; POPULATION RISK; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; RISK ASSESSMENT;

EID: 84890121374     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28396     Document Type: Article

References (25)

1. Sander JW,. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003; 16: 165-170.
2. Christensen J, Vestergaard M, Pedersen MG, Pedersen CB, Olsen J, Sidenius P,. Incidence and prevalence of epilepsy in Denmark. Epilepsy Res 2007; 76: 60-65.
3. Singh G, Driever PH, Sander JW,. Cancer risk in people with epilepsy: the role of anti-epileptic drugs. Brain 2005; 128: 7-17.
4. Bouzahzah B, Pavier D, Barbason H,. The role of corticoids, adrenalectomy, phenobarbital and pentobarbital in the promotion of DEN-hepatocarcinogenesis. In Vivo 1998; 12: 411-419.
5. Clemmensen J,.Hjalgrim-Jensen S., Is phenobarbital carcinogenic? A follow-up of 8078 epileptics. Ecotoxicol Environ Saf 1978; 1: 457-470.
6. Driever PH, Knupfer MM, Cinatl J, Wolff JE,. Valproic acid for the treatment of pediatric malignant glioma. Klin Padiatr 1999; 211: 323-328.
7. Friedman GD, Ury HK,. Screening for possible drug carcinogenicity: second report of findings. J Natl Cancer Inst 1983; 71: 1165-1175.
8. Olsen JH, Boice JD, Jensen JP, Fraumeni JF,. Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst 1989; 81: 803-808.
9. Olsen JH, Schulgen G, Boice JD, Whysner J, Travis LB, Williams GM, Johnson FB, McGee JO,. Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma. Cancer Res 1995; 55: 294-297.
10. Peraino C, Staffeldt EF, Haugen DA, Lombard LS, Stevens FJ, Fry RJ,. Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res 1980; 40: 3268-3273.
11. Sami S, Hoti N, Xu HM, Shen Z, Huang X,. Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo. J Biochem 2008; 144: 357-362.
12. Selby JV, Friedman GD, Fireman BH,. Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res 1989; 49: 5736-5745.
13. Watkins JR, Gough AW, McGuire EJ, Goldenthal E, de la Iglesia FA,. Calcium valproate-induced uterine adenocarcinomas in Wistar rats. Toxicology 1992; 71: 35-47.
14. White SJ, McLean AE, Howland C,. Anticonvulsant drugs and cancer. A cohort study in patients with severe epilepsy. Lancet 1979; 2: 458-461.
15. Hallas J, Friis S, Bjerrum L, Støvring H, Narverud SF, Heyerdahl T, Grønbæk K, Andersen M,. Cancer risk in long-term users of valproate: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2009; 18: 1714-1719.
16. Lamminpää A, Pukkala E, Teppo L, Neuvonen PJ,. Cancer incidence among patients using anti-epileptic drugs: a long-term follow-up of 28,000 patients. Clin Pharmacol 2002; 58: 137-141.
17. Singh G, Bell GS, Driever PH, Sander JW,. Cancer risk in people with epilepsy using valproate-sodium. Acta Neurol Scand 2012; 125: 234-240.
18. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB,. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006; 53: 441-449.
19. Gaist D, Sorensen HT, Hallas J,. The Danish prescription registries. Dan Med Bull 1997; 44: 445-448.
20. WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health, Norway (http://www.whocc.no/atc/structure-and- principles).
21. Storm HH,. The Danish Cancer Registry, a self-reporting national cancer registration system with elements of active data collection. IARC Sci Publ 1991; 95: 220-236.
22. Storm HH, Michelsen EV, Clemmensen IH, Pihl J,. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997; 44: 535-539.
23. Brackenbury WJ,.Isom LL., Voltage-gated Na+ channels: potential for beta subunits as therapeutic targets. Expert Opin Ther Targets 2008; 12: 1191-1203.
24. Brackenbury WJ,.Isom LL., Na channel beta subunits: overachievers of the ion channel family. Front Pharmacol 2011; 2: 53.
25. Eijkelkamp N, Linley JE, Baker MD, Minett MS, Cregg R, Werdehausen R, Rugiero F, Wood JN,. Neurological perspectives on voltage-gated sodium channels. Brain 2012; 135: 2585-2612.